Biotech | August 12, 2025
Sartorius and Nanotein Technologies partner to advance cell therapy manufacturing
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
AINU is set to accelerate its expansion footprint, enhance operational capabilities
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Norepinephrine Bitartratein 5% Dextrose of Baxter Healthcare Corp
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA
This strategic investment strengthens Cohance's integrated oligonucleotide platform
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Consolidated revenue from operations in the quarter was marginally down at Rs 738 crore a
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25
Subscribe To Our Newsletter & Stay Updated
